> top > docs > PubMed:32491073 > annotations

PubMed:32491073 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 603-608 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 603-608 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 14-38 Disease denotes Coronavirus Disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T2 42-65 Disease denotes Cardiovascular Diseases http://purl.obolibrary.org/obo/MONDO_0004995
T3 136-160 Disease denotes Coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T4 162-170 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 252-260 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 377-385 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T7 419-430 Disease denotes myocarditis http://purl.obolibrary.org/obo/MONDO_0004496
T8 573-598 Disease denotes essential in hypertension http://purl.obolibrary.org/obo/MONDO_0001134
T9 586-598 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T10 603-616 Disease denotes heart failure http://purl.obolibrary.org/obo/MONDO_0005252
T11 620-628 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 698-706 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 76-78 http://www.ebi.ac.uk/efo/EFO_0000265 denotes da
T2 175-176 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T3 432-434 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T4 603-608 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T5 603-608 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T6 603-608 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T7 603-608 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 278-289 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T2 513-527 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T3 517-527 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T4 532-543 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2 14-38 Disease denotes Coronavirus Disease 2019 MESH:C000657245
3 42-65 Disease denotes Cardiovascular Diseases MESH:D002318
15 136-160 Disease denotes Coronavirus disease 2019 MESH:C000657245
16 162-170 Disease denotes COVID-19 MESH:C000657245
17 242-250 Species denotes patients Tax:9606
18 252-260 Disease denotes COVID-19 MESH:C000657245
19 377-385 Disease denotes COVID-19 MESH:C000657245
20 419-430 Disease denotes myocarditis MESH:D009205
21 448-456 Species denotes patients Tax:9606
22 586-598 Disease denotes hypertension MESH:D006973
23 603-616 Disease denotes heart failure MESH:D006333
24 620-628 Disease denotes COVID-19 MESH:C000657245
25 698-706 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-66 Sentence denotes The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases.
T2 67-135 Sentence denotes O Efeito da Doença de Coronavírus 2019 nas Doenças Cardiovasculares.
T3 136-251 Sentence denotes Coronavirus disease 2019 (COVID-19) is a global pandemic affecting the world, seen in more than 1,300,000 patients.
T4 252-326 Sentence denotes COVID-19 acts through the angiotensin-converting enzyme 2 (ACE2) receptor.
T5 327-458 Sentence denotes Cardiovascular comorbidities are more common with COVID-19, and nearly 10% of cases develop myocarditis (22% of critical patients).
T6 459-629 Sentence denotes Further research is needed to continue or discontinue ACE inhibitors and angiotensin receptor blockers, which are essential in hypertension and heart failure in COVID-19.
T7 630-707 Sentence denotes Intensive research is promising for the treatment and prevention of COVID-19.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 42-65 Phenotype denotes Cardiovascular Diseases http://purl.obolibrary.org/obo/HP_0001626
T2 419-430 Phenotype denotes myocarditis http://purl.obolibrary.org/obo/HP_0012819
T3 586-598 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T4 603-616 Phenotype denotes heart failure http://purl.obolibrary.org/obo/HP_0001635

ENG_RE_CONSENSUS

Id Subject Object Predicate Lexical cue
T14 136-160 DOID_0080600 denotes Coronavirus disease 2019
T1 162-170 DOID_0080600 denotes COVID-19
T2 252-260 DOID_0080600 denotes COVID-19
T15 327-355 HP_0001626 denotes Cardiovascular comorbidities
T3 377-385 DOID_0080600 denotes COVID-19
T5 419-430 DOID_820 denotes myocarditis
T4 419-430 HP_0012819 denotes myocarditis
T6 513-527 CHEBI_35457 denotes ACE inhibitors
T16 532-561 CHEBI_61016 denotes angiotensin receptor blockers
T9 586-598 HP_0000822 denotes hypertension
T10 586-598 DOID_10763 denotes hypertension
T11 603-616 HP_0001635 denotes heart failure
T12 620-628 DOID_0080600 denotes COVID-19
T13 698-706 DOID_0080600 denotes COVID-19
R10 T10 T6 negative hypertension,ACE inhibitors
R11 T10 T6 negative hypertension,ACE inhibitors
R12 T16 T9 negative angiotensin receptor blockers,hypertension
R13 T16 T11 negative angiotensin receptor blockers,heart failure
R14 T6 T10 negative ACE inhibitors,hypertension
R15 T6 T11 negative ACE inhibitors,heart failure
R16 T15 T3 effect Cardiovascular comorbidities,COVID-19
R17 T5 T3 effect myocarditis,COVID-19
R18 T5 T12 effect myocarditis,COVID-19
R19 T15 T12 effect Cardiovascular comorbidities,COVID-19
R20 T15 T13 effect Cardiovascular comorbidities,COVID-19
R21 T15 T2 effect Cardiovascular comorbidities,COVID-19
R22 T15 T1 effect Cardiovascular comorbidities,COVID-19
R23 T15 T14 effect Cardiovascular comorbidities,Coronavirus disease 2019
R24 T5 T13 effect myocarditis,COVID-19
R25 T5 T2 effect myocarditis,COVID-19
R26 T5 T1 effect myocarditis,COVID-19
R27 T5 T14 effect myocarditis,Coronavirus disease 2019

ENG_NER_NEL_CONSENSUS

Id Subject Object Predicate Lexical cue
T39 136-160 MESH:D000086382 denotes Coronavirus disease 2019
T36 136-160 DOID:0080600 denotes Coronavirus disease 2019
T40 162-170 MESH:D000086382 denotes COVID-19
T5 162-170 DOID:0080600 denotes COVID-19
T41 252-260 MESH:D000086382 denotes COVID-19
T7 252-260 DOID:0080600 denotes COVID-19
T37 278-325 MESH:D011945 denotes angiotensin-converting enzyme 2 (ACE2) receptor
T38 327-355 HP:0001626 denotes Cardiovascular comorbidities
T42 377-385 MESH:D000086382 denotes COVID-19
T13 377-385 DOID:0080600 denotes COVID-19
T17 419-430 MESH:D009205 denotes myocarditis
T16 419-430 HP:0012819 denotes myocarditis
T15 419-430 DOID:820 denotes myocarditis
T20 513-527 CHEBI:35457 denotes ACE inhibitors
T22 532-561 CHEBI:61016 denotes angiotensin receptor blockers
T25 586-598 MESH:D006973 denotes hypertension
T24 586-598 HP:0000822 denotes hypertension
T23 586-598 DOID:10763 denotes hypertension
T29 603-616 MESH:D006333 denotes heart failure
T28 603-616 HP:0001635 denotes heart failure
T27 603-608 MESH:D006321 denotes heart
T44 620-628 MESH:D000086382 denotes COVID-19
T31 620-628 DOID:0080600 denotes COVID-19
T33 640-648 MESH:D012106 denotes research
T43 698-706 MESH:D000086382 denotes COVID-19
T35 698-706 DOID:0080600 denotes COVID-19